A critical advance in cancer research is arising with the use of mini-antibodies to restore mutated p53. This essential malignant suppressor protein is frequently disabled in several kinds of cancer, leading https://bookmarklinx.com/story22009310/vhh-fragments-reactivate-p53-a-promising-approach-for-tumor-management